Project Categories

Has The Revolution Come and Gone? The Societal Value of New Psychotropic Drugs

Award Year: 2006 Investigator: Haiden Huskamp
New drugs for depression, anxiety, schizophrenia, and bipolar disorder have been introduced over the past 20 years, leading to better treatment options for patients and improved management of common mental illnesses. But the wide adoption of these drugs has also created rising public expenditures and large profits for the pharmaceutical industry.

Crossing the Threshold: How Experimental Medical Technology Becomes Standard Care

Award Year: 2000 Investigator: Richard Deyo, Donald Patrick
New medical technologies are a leading cause of escalating health care costs. However, the process by which new technology is disseminated and utilized is highly variable. It is driven not only by scientific evidence but also by the high cultural value placed on health technology in the U.S., profit motives, political concerns, marketing, and the media.